Pet Cancer Therapeutics Market is expected to grow at a CAGR of 9.73% through 2031
Increasing domestication and growing prevalence of cancer to
drive the pet cancer therapeutics market in the forecast period, 2027-2031.
According to TechSci Research report, “Pet Cancer Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031”, the Global Pet Cancer Therapeutics Market will grow from USD 467.69 Million in 2025 to USD 816.41 Million by 2031 at a 9.73% CAGR. The increase in pet ownership and rising awareness
regarding pets’ healthcare are the primary factors driving the demand for the global
pet cancer therapeutics market. Growing advancements in diagnostic therapeutics
and heavy investments in R&D activities are expected to influence the
market demand. Also, the rising trend of pet adoption, such as cats and dogs, due to the improved economic status of people, is also a key factor for increasing the growth of the pet cancer therapeutics market globally.
However, side effects due to cancer
therapeutics in pets and the ignorance of pet owners to put their pets on medications
are curbing the growth of the pet cancer therapeutics market. Also, a limited number of veterinary oncologists and low expenditure on pet healthcare in developing and underdeveloped economies are likely to hamper the growth of the market in the forecast period.
Browse over XX market
data Figures spread through 110 Pages and an in-depth TOC on "Global Pet Cancer Therapeutics Market"
The global pet
cancer therapeutics market is segmented into therapy, animal
type, cancer type, and company.
Based on
therapy, the market is divided into surgery, radiotherapy, chemotherapy,
immunotherapy, and others.
The chemotherapy segment is expected to witness largest market share as it is
the most used therapy to treat pet cancer and has been observed to reach
remission in over 70% of the cases. An effective treatment procedure comprising
chemotherapy is estimated to treat cancer in almost 95% cases of dogs.
Based on animal
type, the market is divided into canine, feline, and others. The
canine segment is anticipated to grow during the forecast period. This is
attributed to more cancer incidence in the breed in comparison to the other
pets and a larger number of cancer therapies available for dogs in the global
marketplace.
Based on cancer
type, the market is segmented into lymphoma, mast cell cancer, mammary &
squamous cell cancer, and others. The lymphoma segment is anticipated to grow during the forecast period as a large number of pets are diagnosed with this disease, and a greater number of medicines are approved for the treatment.
Major
operating companies operating in the global pet cancer therapeutics market are:
- C.H. Boehringer Sohn Ko. KG
- ELIAS Animal Health, LLC
- Zoetis Inc.
- AB Science S.A.
- Karyopharm Therapeutics, Inc.
- Vivesto AB
- Merial Inc.
- Elanco Animal Health, Inc.
- Dechra Pharmaceuticals PLC
- Torigen Pharmaceuticals Inc
Download Free Sample Report
Customers can also request a 10% free customisation on this report.
The North America region
dominates the market in 2021 and is expected to maintain its dominance in the
coming years due to growing consciousness of pets’ health and increasing
incidences of cancer among animals. Also, rising pet adoption, increasing per capita expenditure on animal healthcare, and presence of robust healthcare infrastructure facilities are expected to propel the global pet cancer therapeutics market growth till 2027,” said Mr Karan Chechi, Research Director with TechSci Research, a research-based global management consulting firm.
“Pet Cancer Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapy (Surgery, Radiotherapy, Chemotherapy, Immunotherapy, Others), By Animal Type (Canine, Feline, Others), By Cancer Type (Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer, Others), By Company, and By Region 2021-2031F”, has evaluated the future
growth potential of global pet cancer therapeutics and provides statistics
& information on market size, structure, and future market growth. The
report intends to provide cutting-edge market intelligence and help decision
makers take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in global pet cancer therapeutics market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com